DBV Technologies (DBVT) Free Cash Flow (2020 - 2026)

DBV Technologies (DBVT) posted quarterly Free Cash Flow of -$53.0 million for Q2 2026, down 56.34% year-on-year from -$121.4 million in Q2 2025, and down 7.07% on a QoQ basis from -$49.5 million in Q1 2026.

DBV Technologies (DBVT) Free Cash Flow (2020 - 2026) Analysis & Trends

DBV Technologies (DBVT) has reported Free Cash Flow for 7 consecutive years, with -$53.0 million the latest figure, recorded in Q2 2026.

  • Quarterly Free Cash Flow fell 56.34% year-over-year to -$53.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$170.6 million (down 92.61% YoY) and the FY2025 annual result came in at -$121.7 million, down 13.95% from the prior year.
  • Free Cash Flow retreated to -$53.0 million in Q2 2026 per DBVT's latest filing, from -$49.5 million in the prior quarter.
  • Over the last five years, Free Cash Flow for DBVT reached as high as -$1.6 million in Q1 2022 and fell as low as -$53.0 million in Q2 2026.
  • A 5-year average of -$26.0 million and a median of -$23.4 million in 2022 frame the typical range for Free Cash Flow.
  • Annual changes were most pronounced in 2022 — Free Cash Flow jumped 95.56% — and 2023, when it slumped 1198.14%.
  • Year by year, Free Cash Flow stood at -$23.9 million in 2022, then surged by 41.26% to -$14.0 million in 2023, then advanced by 13.61% to -$12.1 million in 2024, then sank by 193.11% to -$35.5 million in 2025, then plunged by 49.1% to -$53.0 million in 2026.
  • According to Business Quant data, Free Cash Flow over the past three periods registered -$53.0 million, -$49.5 million, and -$35.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -19.58 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 158.09 Mn
4 NuCana 279.75 Bn 279.75 Bn - -1.53 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.29 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 848.30 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -354.95 Mn
10 DBV Technologies 267.50 Mn 92.60 Mn - -53.00 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -53.00 Mn
Jun 30, 2026 -53.00 Mn
Mar 31, 2026 -49.50 Mn
Mar 31, 2026 -49.50 Mn
Dec 31, 2025 -35.55 Mn
Dec 31, 2025 -35.55 Mn
Sep 30, 2025 -32.57 Mn
Sep 30, 2025 -32.57 Mn
Jun 30, 2025 -33.90 Mn
Jun 30, 2025 -33.90 Mn
Mar 31, 2025 -19.70 Mn
Mar 31, 2025 -19.70 Mn
Dec 31, 2024 -12.13 Mn
Dec 31, 2024 -12.13 Mn
Sep 30, 2024 -22.85 Mn
Sep 30, 2024 -22.85 Mn
Jun 30, 2024 -35.81 Mn
Jun 30, 2024 -35.81 Mn
Mar 31, 2024 -36.03 Mn
Mar 31, 2024 -36.03 Mn